Semaglutide: Which dose for which patient Part 1: Your questions answered

   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 hours

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 hours

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 hours

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia.

  1. Can you start on Ozempic and up titrate to 1 milligram and then switch to Wegovy if one milligram is not enough OR is the goal to up titrate to 2.4 as it is the most effective dose, so prescribing Wegovy instead?
  2. How you can switch between Ozempic to Wegovy?
  3. How about switching from semaglutide to tirzepatide, and liraglutide and saxenda?
  4. How quickly will you increase the dose and what dose do we aim for?
  5. What are your thoughts on patients that are responding to lower doses but are being prescribed a higher dose pen and trying to micro dose with a larger pen.
  6. How long do you keep the patients on semaglutide and when do you stop?
  7. When do you even think about the intermittent use of such an agent?
  8. Can semaglutide be given for life?
  9. Can the medication be given fortnightly instead of weekly?
  10. Patients that want to re-start, will they restart at the dose they stopped at or at a lower dose?
  11. Is there a BMI target for patients with T2D?
  12. Position statement on T2D remission: When are they going to update and add in the GLP ones?
  13. Do we use the same dose or higher doses of Wegovy for adolescence?
  14. What do you think about the use of semaglutide for an adolescent with autism or an adolescent using an anti-psychotic medication such as Clozapine who needs to take it on an ongoing basis?
  15. Has the use of semaglutide increased the incidence of restrictive eating disorders?
  16. Any indication for use in women with polycystic ovarian syndrome?

 

Expert: A/Prof Ralph Audehm, General Practitioner

Host: Dr David Lim, GP and Medical Educator

Total time: 28 mins

 

Last Updated: 3 Dec, 2024

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Li-Chuen Wong

A/Prof Li-Chuen Wong

Eczema Practical Updates for General Practice

Dr Preeti Joshi

Dr Preeti Joshi

Cow’s Milk Allergy in Infants and Children

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

RSV Vaccine on the NIP – What You Need to Know

A/Prof Adrian Mar

A/Prof Adrian Mar

Vitiligo – Early Detection and Early Treatment

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

Eczema Practical Updates for General Practice

Tuesday 12th May, 7pm - 9pm AEST

Speaker

A/Prof Li-Chuen Wong

Consultant Dermatologist; Senior Specialist Visiting Medical Officer, Head, Dermatology Department, Children's Hospital at Westmead

In this talk, Associate Professor Li-Chuen Wong will outline a practical, structured approach to managing these patients. We invite you to join the next Healthed webcast.